Search

Meeting Coverage:

American Society of Retina Specialists Annual Meeting

ASRS: 2020

RGX-314: Phase 1/2a Data

Arshad Khanani, MD

Show Description +

Arshad Khanani, MD, provides updates on visual and anatomic data from a phase 1/2a trial evaluating the safety and efficacy of RGX-314 (RegenxBio) in patients with wet AMD. New data from the two cohorts that received the highest dose of the drug are delivered during this summary of his ASRS 2020 lecture.

Posted: 7/28/2020

Keywords:

Clinical Cases

•

REGENXBIO

•

retina-meeting-recap

•

Wet AMD

Up Next

Intravitreal Methotrexate in the Prevention of Recurrent RD After PVR

Intravitreal Methotrexate in the Prevention of Recurrent RD After PVR

Scott Walter, MD

Using 3-Month Outcomes to Predict Long-Term Vision Outcomes in Wet AMD Patients

Using 3-Month Outcomes to Predict Long-Term Vision Outcomes in Wet AMD Patients

Paul Hahn, MD, PhD

AU-011 for Choroidal Melanoma

AU-011 for Choroidal Melanoma

Ivana Kim, MD

Mathematical Model for Outcomes in CEDAR and SEQUOIA

Mathematical Model for Outcomes in CEDAR and SEQUOIA

Peter Kaiser, MD

Demographics in PANORAMA Patients

Demographics in PANORAMA Patients

Nathan Steinle, MD

Sustained Release Fluocinolone Acetonide for Uveitis

Sustained Release Fluocinolone Acetonide for Uveitis

Dilraj Grewal, MD

MVP: A New Surgical Tool

MVP: A New Surgical Tool

Carl C. Awh, MD

PDR Treatment Patterns

PDR Treatment Patterns

Jeremiah Brown Jr, MD, MS

Next-Generation Intraoperative OCT

Next-Generation Intraoperative OCT

Lejla Vajzovic, MD

Back to All Videos

RGX-314: Phase 1/2a Data

Arshad Khanani, MD

Arshad Khanani, MD, provides updates on visual and anatomic data from a phase 1/2a trial evaluating the safety and efficacy of RGX-314 (RegenxBio) in patients with wet AMD. New data from the two cohorts that received the highest dose of the drug are delivered during this summary of his ASRS 2020 lecture.

Posted: 7/28/2020

Keywords:

Clinical Cases

•

REGENXBIO

•

retina-meeting-recap

•

Wet AMD

Please log in to leave a comment.

More From ASRS: 2020 Coverage

Demographics in PANORAMA Patients

Demographics in PANORAMA Patients

Nathan Steinle, MD

Sustained Release Fluocinolone Acetonide for Uveitis

Sustained Release Fluocinolone Acetonide for Uveitis

Dilraj Grewal, MD

MVP: A New Surgical Tool

MVP: A New Surgical Tool

Carl C. Awh, MD

PDR Treatment Patterns

PDR Treatment Patterns

Jeremiah Brown Jr, MD, MS

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2020.